HIGHFDA DRUG

Kirkman MAXIMUM Zone 1 4% Lidocaine Cream Recall 178 Bottles (2026)

Kirkman recalled 178 bottles of MAXIMUM Zone 1 4% Lidocaine Cream distributed nationwide in the U.S. by Dermal Source. The recall cites stability data that does not support the stated expiry date. Consumers and healthcare providers should stop using this product immediately and contact Kirkman for guidance.

Official notice
KirkmanHealth & Personal CareDrugs & MedicationsLot #: 807CP-0003Exp. Date 07/31/2026.

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
February 18, 2026
Status
ACTIVE
Severity
7/10

Quick Facts at a Glance

Recall Date
February 18, 2026
Hazard Level
HIGH
Brand
Kirkman
Category
Health & Personal Care
Sold At
Unknown
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Kirkman
Product type
Lidocaine Cream
Model numbers
Lot #: 807CP-0003, Exp. Date 07/31/2026.
Sizes
1/2 oz
Sold at
Unknown
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    February 18, 2026

  2. Reported by FDA DRUG

    March 11, 2026

  3. RecallRadar source check

    March 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Stability Data Does Not Support Expiry Date.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact HTO Nevada Inc. dba Kirkman or your healthcare provider for guidance. Notification method: E-Mail

About This Product

MAXIMUM Zone 1 4% Lidocaine Cream is a topical anesthetic intended for minor skin procedures or analgesia in adults. Packaged in 1/2 oz bottles.

Why This Is Dangerous

Stability data does not support the expiry date. Using expired lidocaine cream may result in reduced potency or unsafe outcomes.

Industry Context

This recall is not described as part of a broader industry pattern.

Real-World Impact

Consumers may experience reduced effectiveness or unknown safety risk if used past expiry date. Immediate suspension of use is advised.

Practical Guidance

How to identify if yours is affected

  1. Check bottle label for Lot #: 807CP-0003.
  2. Check Expiry date: 07/31/2026.
  3. Verify distributor: Dermal Source on packaging.

Where to find product info

Recall details available at the FDA enforcement report for D-0386-2026.

What timeline to expect

Not specified in the recall notice.

If the manufacturer is unresponsive

  • Document contact attempts to Kirkman by email
  • Consider reporting to health authorities if safety concerns persist

How to prevent similar issues

  • Check expiry dates before using any topical medication.
  • Buy from reputable distributors and verify lot numbers.
  • Keep medication out of reach of children.

Documentation advice

Keep the bottle, packaging, and recall notice. Save email communications with Kirkman.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Product: MAXIMUM Zone 1 4% Lidocaine Cream, 1/2 oz bottles. NDC: 80069-014. Lot #: 807CP-0003. Expiry date: 07/31/2026. Sold nationwide in the U.S. Distribution: Dermal Source, Portland, OR 97232. Quantity: 178 bottles.

Key Facts

  • Distributed nationwide in the U.S. by Dermal Source
  • Recall date 2026-02-18; status ACTIVE

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
7/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Details

Brand
Model Numbers
Lot #: 807CP-0003
Exp. Date 07/31/2026.
Affected States
ALL
Report Date
March 11, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

LACTATED RINGERS
Presence of
Read more